Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 SALES VOLUME
2.2.11 EPIDEMIOLOGY MODELLING
2.2.12 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.13 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6. INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7. INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8. COST ANALYSIS BREAKDOWN
9. TECHNONLOGY ROADMAP
10. INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11. REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12. REIMBURSEMENT FRAMEWORK
13. OPPUTUNITY MAP ANALYSIS
14. VALUE CHAIN ANALYSIS
15. HEALTHCARE ECONOMY
15.1 HEALTHCARE EXPENDITURE
15.2 CAPITAL EXPENDITURE
15.3 CAPEX TRENDS
15.4 CAPEX ALLOCATION
15.5 FUNDING SOURCES
15.6 INDUSTRY BENCHMARKS
15.7 GDP RATION IN OVERALL GDP
15.8 HEALTHCARE SYSTEM STRUCTURE
15.9 GOVERNMENT POLICIES
15.10 ECONOMIC DEVELOPMENT
16. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRODUCT TYPE
16.1 OVERVIEW
16.2 ORAL SUPPLEMENTS
16.2.1 PURE BIOTIN SUPPLEMENTS
16.2.1.1. HIGH-POTENCY BIOTIN SUPPLEMENTS
16.2.1.2. TIME-RELEASE BIOTIN SUPPLEMENTS
16.2.1.3. VEGAN AND ORGANIC BIOTIN SUPPLEMENTS
16.2.1.4. LIQUID BIOTIN FORMULATIONS
16.2.1.5. OTHERS
16.2.2 MULTIVITAMIN COMPLEXES CONTAINING BIOTIN
16.2.3 BIOTIN-ENRICHED HAIR CARE PRODUCTS
16.2.3.1. SHAMPOOS
16.2.3.2. CONDITIONERS
16.2.3.3. HAIR OILS
16.2.3.4. SERUMS
16.2.3.5. OTHERS
16.2.4 GUMMIES AND CHEWABLES WITH BIOTIN
16.2.5 BIOTIN-INFUSED FUNCTIONAL BEVERAGES
16.2.6 AMINO ACID COMPLEXES
16.2.7 OMEGA-3 FATTY ACID CAPSULES
16.2.8 COLLAGEN POWDERS
16.2.9 HERBAL SUPPLEMENTS
16.2.10 OTHERS
16.3 TOPICAL TREATMENTS
16.3.1 HAIR LOSS SHAMPOOS
16.3.2 CONDITIONERS WITH KERATIN AND BIOTIN
16.3.3 SERUMS (MINOXIDIL, BIOTIN-ENRICHED)
16.3.4 HAIR OILS (ARGAN OIL, CASTOR OIL, ONION OIL)
16.3.5 SCALP MASKS AND SCRUBS
16.4 PHARMACEUTICAL SOLUTIONS
16.4.1 MINOXIDIL (ROGAINE)
16.4.2 FINASTERIDE (PROPECIA)
16.4.3 DUTASTERIDE
16.4.4 ANTI-DHT TOPICAL FORMULATIONS
16.5 OTHERS
17. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRODUCT FORM
17.1 OVERVIEW
17.2 TABLETS
17.3 CAPSULES
17.4 GUMMIES
17.5 POWDERS
17.6 LIQUID DROPS
17.7 SPRAYS
17.8 OTHER
18. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY APPLICATION TYPE
18.1 OVERVIEW
18.2 ALOPECIA AREATA
18.3 MALE PATTERN BALDNESS
18.4 FEMALE PATTERN HAIR LOSS
18.5 POSTPARTUM HAIR LOSS
18.6 HAIR THINNING DUE TO STRESS
18.7 OTHERS
19. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY PRICE RANGE
19.1 OVERVIEW
19.2 ENTRY-LEVEL (MASS MARKET)
19.3 MID-RANGE PRODUCTS
19.4 PREMIUM PRODUCTS
20. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
20.1 OVERVIEW
20.2 DIRECT TENDER
20.3 RETAILS
20.3.1 ONLINE
20.3.2 OFFLINE
21. GLOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION
21.1 GLOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
21.1.1 NORTH AMERICA
21.1.1.1. U.S.
21.1.1.2. CANADA
21.1.1.3. MEXICO
21.1.2 EUROPE
21.1.2.1. GERMANY
21.1.2.2. FRANCE
21.1.2.3. U.K.
21.1.2.4. HUNGARY
21.1.2.5. LITHUANIA
21.1.2.6. AUSTRIA
21.1.2.7. IRELAND
21.1.2.8. NORWAY
21.1.2.9. POLAND
21.1.2.10. ITALY
21.1.2.11. SPAIN
21.1.2.12. RUSSIA
21.1.2.13. TURKEY
21.1.2.14. NETHERLANDS
21.1.2.15. SWITZERLAND
21.1.2.16. REST OF EUROPE
21.1.3 ASIA-PACIFIC
21.1.3.1. JAPAN
21.1.3.2. CHINA
21.1.3.3. SOUTH KOREA
21.1.3.4. INDIA
21.1.3.5. AUSTRALIA
21.1.3.6. SINGAPORE
21.1.3.7. THAILAND
21.1.3.8. MALAYSIA
21.1.3.9. INDONESIA
21.1.3.10. PHILIPPINES
21.1.3.11. VIETNAM
21.1.3.12. REST OF ASIA-PACIFIC
21.1.4 SOUTH AMERICA
21.1.4.1. BRAZIL
21.1.4.2. ARGENTINA
21.1.4.3. PERU
21.1.4.4. REST OF SOUTH AMERICA
21.1.5 MIDDLE EAST AND AFRICA
21.1.5.1. SOUTH AFRICA
21.1.5.2. SAUDI ARABIA
21.1.5.3. UAE
21.1.5.4. EGYPT
21.1.5.5. KUWAIT
21.1.5.6. ISRAEL
21.1.5.7. REST OF MIDDLE EAST AND AFRICA
21.1.6 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
22. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, SWOT AND DBMR ANALYSIS
23. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, COMPANY LANDSCAPE
23.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
23.2 MERGERS & ACQUISITIONS
23.3 NEW PRODUCT DEVELOPMENT & APPROVALS
23.4 EXPANSIONS
23.5 REGULATORY CHANGES
23.6 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
24. GLOBAL HAIR LOSS TREATMENT PRODUCTS MARKET, COMPANY PROFILE
24.1 CIPLA
24.1.1 COMPANY OVERVIEW
24.1.2 REVENUE ANALYSIS
24.1.3 GEOGRAPHIC PRESENCE
24.1.4 PRODUCT PORTFOLIO
24.1.5 RECENT DEVELOPEMENTS
24.2 VIVISCAL
24.2.1 COMPANY OVERVIEW
24.2.2 REVENUE ANALYSIS
24.2.3 GEOGRAPHIC PRESENCE
24.2.4 PRODUCT PORTFOLIO
24.2.5 RECENT DEVELOPEMENTS
24.3 PFIZER INC.
24.3.1 COMPANY OVERVIEW
24.3.2 REVENUE ANALYSIS
24.3.3 GEOGRAPHIC PRESENCE
24.3.4 PRODUCT PORTFOLIO
24.3.5 RECENT DEVELOPEMENTS
24.4 DR. REDDY’S LABORATORIES LTD.
24.4.1 COMPANY OVERVIEW
24.4.2 REVENUE ANALYSIS
24.4.3 GEOGRAPHIC PRESENCE
24.4.4 PRODUCT PORTFOLIO
24.4.5 RECENT DEVELOPEMENTS
24.5 REGAINE
24.5.1 COMPANY OVERVIEW
24.5.2 REVENUE ANALYSIS
24.5.3 GEOGRAPHIC PRESENCE
24.5.4 PRODUCT PORTFOLIO
24.5.5 RECENT DEVELOPEMENTS
24.6 CONCERT PHARMACEUTICALS
24.6.1 COMPANY OVERVIEW
24.6.2 REVENUE ANALYSIS
24.6.3 GEOGRAPHIC PRESENCE
24.6.4 PRODUCT PORTFOLIO
24.6.5 RECENT DEVELOPEMENTS
24.7 MERCK & CO., INC
24.7.1 COMPANY OVERVIEW
24.7.2 REVENUE ANALYSIS
24.7.3 GEOGRAPHIC PRESENCE
24.7.4 PRODUCT PORTFOLIO
24.7.5 RECENT DEVELOPEMENTS
24.8 SUN PHARMACEUTICAL INDUSTRIES LTD.
24.8.1 COMPANY OVERVIEW
24.8.2 REVENUE ANALYSIS
24.8.3 GEOGRAPHIC PRESENCE
24.8.4 PRODUCT PORTFOLIO
24.8.5 RECENT DEVELOPEMENTS
24.9 ABBOTT
24.9.1 COMPANY OVERVIEW
24.9.2 REVENUE ANALYSIS
24.9.3 GEOGRAPHIC PRESENCE
24.9.4 PRODUCT PORTFOLIO
24.9.5 RECENT DEVELOPEMENTS
24.10 ALES GROUP SINGAPORE PTE. LTD
24.10.1 COMPANY OVERVIEW
24.10.2 REVENUE ANALYSIS
24.10.3 GEOGRAPHIC PRESENCE
24.10.4 PRODUCT PORTFOLIO
24.10.5 RECENT DEVELOPEMENTS
24.11 COSTCO WHOLESALE CORPORATION (KIRKLAND SUGNATURE)
24.11.1 COMPANY OVERVIEW
24.11.2 REVENUE ANALYSIS
24.11.3 GEOGRAPHIC PRESENCE
24.11.4 PRODUCT PORTFOLIO
24.11.5 RECENT DEVELOPEMENTS
24.12 JOHNSON & JOHNSON CONSUMER INC.
24.12.1 COMPANY OVERVIEW
24.12.2 REVENUE ANALYSIS
24.12.3 GEOGRAPHIC PRESENCE
24.12.4 PRODUCT PORTFOLIO
24.12.5 RECENT DEVELOPEMENTS
24.13 VITABIOTICS LTD.
24.13.1 COMPANY OVERVIEW
24.13.2 REVENUE ANALYSIS
24.13.3 GEOGRAPHIC PRESENCE
24.13.4 PRODUCT PORTFOLIO
24.13.5 RECENT DEVELOPEMENTS
24.14 NANOGEN
24.14.1 COMPANY OVERVIEW
24.14.2 REVENUE ANALYSIS
24.14.3 GEOGRAPHIC PRESENCE
24.14.4 PRODUCT PORTFOLIO
24.14.5 RECENT DEVELOPEMENTS
24.15 DR. KURT WOLFF GMBH & CO. KG
24.15.1 COMPANY OVERVIEW
24.15.2 REVENUE ANALYSIS
24.15.3 GEOGRAPHIC PRESENCE
24.15.4 PRODUCT PORTFOLIO
24.15.5 RECENT DEVELOPEMENTS
24.16 HISTOGEN INC
24.16.1 COMPANY OVERVIEW
24.16.2 REVENUE ANALYSIS
24.16.3 GEOGRAPHIC PRESENCE
24.16.4 PRODUCT PORTFOLIO
24.16.5 RECENT DEVELOPEMENTS
24.17 ACLARIS THERAPEUTICS, INC.
24.17.1 COMPANY OVERVIEW
24.17.2 REVENUE ANALYSIS
24.17.3 GEOGRAPHIC PRESENCE
24.17.4 PRODUCT PORTFOLIO
24.17.5 RECENT DEVELOPEMENTS
24.18 HCELL INC.
24.18.1 COMPANY OVERVIEW
24.18.2 REVENUE ANALYSIS
24.18.3 GEOGRAPHIC PRESENCE
24.18.4 PRODUCT PORTFOLIO
24.18.5 RECENT DEVELOPEMENTS
24.19 GLAXOSMITHKLINE
24.19.1 COMPANY OVERVIEW
24.19.2 REVENUE ANALYSIS
24.19.3 GEOGRAPHIC PRESENCE
24.19.4 PRODUCT PORTFOLIO
24.19.5 RECENT DEVELOPMENTS
24.20 PERRIGO COMPANY PLC
24.20.1 COMPANY OVERVIEW
24.20.2 REVENUE ANALYSIS
24.20.3 GEOGRAPHIC PRESENCE
24.20.4 PRODUCT PORTFOLIO
24.20.5 RECENT DEVELOPEMENTS
24.21 ALLERGAN
24.21.1 COMPANY OVERVIEW
24.21.2 REVENUE ANALYSIS
24.21.3 GEOGRAPHIC PRESENCE
24.21.4 PRODUCT PORTFOLIO
24.21.5 RECENT DEVELOPMENTS
24.22 CASSIOPEA, INC.
24.22.1 COMPANY OVERVIEW
24.22.2 REVENUE ANALYSIS
24.22.3 GEOGRAPHIC PRESENCE
24.22.4 PRODUCT PORTFOLIO
24.22.5 RECENT DEVELOPEMENTS
24.23 HISTOGEN INC.
24.23.1 COMPANY OVERVIEW
24.23.2 REVENUE ANALYSIS
24.23.3 GEOGRAPHIC PRESENCE
24.23.4 PRODUCT PORTFOLIO
24.23.5 RECENT DEVELOPEMENTS
24.24 FOLLICUM AB
24.24.1 COMPANY OVERVIEW
24.24.2 REVENUE ANALYSIS
24.24.3 GEOGRAPHIC PRESENCE
24.24.4 PRODUCT PORTFOLIO
24.24.5 RECENT DEVELOPEMENTS
24.25 LEXINGTON INTL., LLC.
24.25.1 COMPANY OVERVIEW
24.25.2 REVENUE ANALYSIS
24.25.3 GEOGRAPHIC PRESENCE
24.25.4 PRODUCT PORTFOLIO
24.25.5 RECENT DEVELOPMENTS
24.26 PURETECH
24.26.1 COMPANY OVERVIEW
24.26.2 REVENUE ANALYSIS
24.26.3 GEOGRAPHIC PRESENCE
24.26.4 PRODUCT PORTFOLIO
24.26.5 RECENT DEVELOPEMENTS
24.27 AMOREPACIFIC CORPORATION
24.27.1 COMPANY OVERVIEW
24.27.2 REVENUE ANALYSIS
24.27.3 GEOGRAPHIC PRESENCE
24.27.4 PRODUCT PORTFOLIO
24.27.5 RECENT DEVELOPMENTS
24.28 LG HOUSEHOLD & HEALTH CARE
24.28.1 COMPANY OVERVIEW
24.28.2 REVENUE ANALYSIS
24.28.3 GEOGRAPHIC PRESENCE
24.28.4 PRODUCT PORTFOLIO
24.28.5 RECENT DEVELOPMENTS
24.29 KERASYS
24.29.1 COMPANY OVERVIEW
24.29.2 REVENUE ANALYSIS
24.29.3 GEOGRAPHIC PRESENCE
24.29.4 PRODUCT PORTFOLIO
24.29.5 RECENT DEVELOPMENTS
24.30 MEDIHEAL
24.30.1 COMPANY OVERVIEW
24.30.2 REVENUE ANALYSIS
24.30.3 GEOGRAPHIC PRESENCE
24.30.4 PRODUCT PORTFOLIO
24.30.5 RECENT DEVELOPMENTS
24.31 TONYMOLY
24.31.1 COMPANY OVERVIEW
24.31.2 REVENUE ANALYSIS
24.31.3 GEOGRAPHIC PRESENCE
24.31.4 PRODUCT PORTFOLIO
24.31.5 RECENT DEVELOPMENTS
24.32 HANBANG
24.32.1 COMPANY OVERVIEW
24.32.2 REVENUE ANALYSIS
24.32.3 GEOGRAPHIC PRESENCE
24.32.4 PRODUCT PORTFOLIO
24.32.5 RECENT DEVELOPMENTS
24.33 ELISHACOY
24.33.1 COMPANY OVERVIEW
24.33.2 REVENUE ANALYSIS
24.33.3 GEOGRAPHIC PRESENCE
24.33.4 PRODUCT PORTFOLIO
24.33.5 RECENT DEVELOPMENTS
24.34 NATURE REPUBLIC
24.34.1 COMPANY OVERVIEW
24.34.2 REVENUE ANALYSIS
24.34.3 GEOGRAPHIC PRESENCE
24.34.4 PRODUCT PORTFOLIO
24.34.5 RECENT DEVELOPMENTS
24.35 ARIUL
24.35.1 COMPANY OVERVIEW
24.35.2 REVENUE ANALYSIS
24.35.3 GEOGRAPHIC PRESENCE
24.35.4 PRODUCT PORTFOLIO
24.35.5 RECENT DEVELOPMENTS
24.36 AESTHETIC HOUSE
24.36.1 COMPANY OVERVIEW
24.36.2 REVENUE ANALYSIS
24.36.3 GEOGRAPHIC PRESENCE
24.36.4 PRODUCT PORTFOLIO
24.36.5 RECENT DEVELOPMENTS
24.37 DR. FOR HAIR (GLOBALN BIOTECH INC.)
24.37.1 COMPANY OVERVIEW
24.37.2 REVENUE ANALYSIS
24.37.3 GEOGRAPHIC PRESENCE
24.37.4 PRODUCT PORTFOLIO
24.37.5 RECENT DEVELOPMENTS
24.38 INNOHERB
24.38.1 COMPANY OVERVIEW
24.38.2 REVENUE ANALYSIS
24.38.3 GEOGRAPHIC PRESENCE
24.38.4 PRODUCT PORTFOLIO
24.38.5 RECENT DEVELOPMENTS
24.39 LANEIGE
24.39.1 COMPANY OVERVIEW
24.39.2 REVENUE ANALYSIS
24.39.3 GEOGRAPHIC PRESENCE
24.39.4 PRODUCT PORTFOLIO
24.39.5 RECENT DEVELOPMENTS
24.40 HERA
24.40.1 COMPANY OVERVIEW
24.40.2 REVENUE ANALYSIS
24.40.3 GEOGRAPHIC PRESENCE
24.40.4 PRODUCT PORTFOLIO
24.40.5 RECENT DEVELOPMENTS
24.41 COSRX
24.41.1 COMPANY OVERVIEW
24.41.2 REVENUE ANALYSIS
24.41.3 GEOGRAPHIC PRESENCE
24.41.4 PRODUCT PORTFOLIO
24.41.5 RECENT DEVELOPMENTS
24.42 MISSHA
24.42.1 COMPANY OVERVIEW
24.42.2 REVENUE ANALYSIS
24.42.3 GEOGRAPHIC PRESENCE
24.42.4 PRODUCT PORTFOLIO
24.42.5 RECENT DEVELOPMENTS
24.43 SIMPLYO
24.43.1 COMPANY OVERVIEW
24.43.2 REVENUE ANALYSIS
24.43.3 GEOGRAPHIC PRESENCE
24.43.4 PRODUCT PORTFOLIO
24.43.5 RECENT DEVELOPMENTS
24.44 SHISEIDO PROFESSIONAL
24.44.1 COMPANY OVERVIEW
24.44.2 REVENUE ANALYSIS
24.44.3 GEOGRAPHIC PRESENCE
24.44.4 PRODUCT PORTFOLIO
24.44.5 RECENT DEVELOPMENTS
24.45 BIODERMA
24.45.1 COMPANY OVERVIEW
24.45.2 REVENUE ANALYSIS
24.45.3 GEOGRAPHIC PRESENCE
24.45.4 PRODUCT PORTFOLIO
24.45.5 RECENT DEVELOPMENTS
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
25. RELATED REPORTS
26. QUESTIONNAIRE
27. CONCLUSION
28. ABOUT DATA BRIDGE MARKET RESEARCH
